Helsinki, Finland – The Solubility Company, an innovative preclinical CRO company, has appointed Jussi Hacklin as its Digital Business Advisor. The role will involve working closely with The Solubility Company to expand the ways pharma companies benefit from its proprietary SPATM drug property data in fast-tracking their drugs to the market.
The Solubility Company’s proprietary SPATM technology produces vast amounts of drug physicochemical data for small molecules and peptides across a practically unlimited solute and solvent chemical space. In his role as Digital Business Advisor Jussi Hacklin will utilize his extensive experience to provide expert guidance and strategically support the commercialization of The Solubility Company’s SPATM drug property data.
Jussi Hacklin has broad experience in the software development industry leading multidisciplinary teams. He has worked in product and consultancy companies building global software business around the world. Currently he is Vice President of Technology at Futurice, an international innovation consultancy that helps companies put data to work, rethink customer experiences and design entirely new business models.
The appointment of a Digital Business Advisor is a statement of The Solubility Company’s ambition to reduce attrition in the pharmaceutical pipeline. The Solubility Company’s technology will be applied to address key bottlenecks in pharmaceutical development, such as poor solubility and bioavailability, and enable fast-tracking drugs to the market through earlier informed decision-making.
Sami Svanbäck, CEO of The Solubility Company said: “We are delighted to be working with Jussi on the positioning and strategy of our SPATM data. Our technology has the ability to significantly enhance the efficiency of pharmaceutical development, and with Jussi on board, we will continue to support our pharma partners by fast-tracking their drugs to the market.”
Jussi Hacklin said: “I have always been excited by all aspects of digital business, especially the meeting point of the physical and digital world. I was attracted to The Solubility Company’s multidisciplinary approach for advanced drug analysis and the great purpose that the company serves. I look forward to helping The Solubility Company position its game-changing technology within the pharmaceutical market.”
Notes to the Editor
About The Solubility Company Oy
The Solubility Company Oy is a contract research organization, focusing on early-stage solubility measurement services for pharmaceutical companies, based on its proprietary image-based SPA™ (Single Particle Analysis) method. The patented SPA™ technology brings the benefit of minimal sample consumption combined with speed and accuracy to the pharmaceutical research and development and to the benefit of the patients. The Solubility Company’s service laboratory, located in Helsinki, Finland, serves customers around the world.
Sami Svanbäck, CEO